Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey

被引：0
|
作者：
Hiroki Murayama
Kota Imai
Masato Odawara
机构：
[1] Novartis Pharma K.K,Medical Division
[2] Tokyo Medical University,Department of Diabetes, Endocrinology, Metabolism, and Rheumatology
来源：
Diabetes Therapy | 2018年 / 9卷
关键词：
Dipeptidyl peptidase-4 inhibitor; Diabetes nonspecialist; Diabetes specialist; Drug-naive; Japan; First line; Metformin; Online survey; Oral antidiabetes drugs; Treatment choices; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1185 / 1199
页数：14
相关论文
共 50 条
  • [41] Characteristics and outcomes of patients with type 2 diabetes mellitus treated with canagliflozin: a real-world analysis
    Buysman, Erin K.
    Chow, Wing
    Henk, Henry J.
    Rupnow, Marcia F. T.
    BMC ENDOCRINE DISORDERS, 2015, 15
  • [42] First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia
    Tsai, Shih-Tzer
    Pathan, Faruque
    Ji, Linong
    Yeung, Vincent Tok Fai
    Chadha, Manoj
    Suastika, Ketut
    Son, Hyun Shik
    Tan, Kevin Eng Kiat
    Benjasuratwong, Yupin
    Thy Khue Nguyen
    Iqbal, Farrukh
    JOURNAL OF DIABETES, 2011, 3 (03) : 208 - 216
  • [43] Consequences of Nonmedical Switch among Patients on Type 2 Diabetes Medications in a Real-World Setting
    Flores, Natalia M.
    Patel, Charmi A.
    Bookhart, Brahim K.
    Bacchus, Shaffeeulah
    DIABETES, 2017, 66 : A361 - A361
  • [44] Metformin dosage patterns in type 2 diabetes patients in a real-world setting in the United States
    Mahabaleshwarkar, Rohan
    DeSantis, Andrea
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 172
  • [45] Real-world effectiveness of imeglimin in patients with type 2 diabetes: A retrospective longitudinal study in Japan
    Katsuyama, Hisayuki
    Hakoshima, Mariko
    Heshiki, Takahiro
    Iida, Sakura
    Adachi, Hiroki
    Yanai, Hidekatsu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 213
  • [46] Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naive Patients with Type 2 Diabetes Mellitus
    Kong, Sung Hye
    Koo, Bo Kyung
    Moon, Min Kyong
    DIABETES & METABOLISM JOURNAL, 2019, 43 (05) : 711 - 717
  • [47] Treatment patterns of drug-naive patients with type 2 diabetes mellitus: a retrospective cohort study using a Japanese hospital database
    Morita, Yohei
    Murayama, Hiroki
    Odawara, Masato
    Bauer, Melissa
    DIABETOLOGY & METABOLIC SYNDROME, 2019, 11 (01):
  • [48] Real-World Outcomes of Patients with Type 2 Diabetes Mellitus (T2DM) Treated with Canagliflozin in a US Managed Care Setting
    Chow, Wing
    Buysman, Erin K.
    Rupnow, Marcia F. T.
    Henk, Henry J.
    DIABETES, 2015, 64 : A347 - A348
  • [49] Treatment patterns of drug-naive patients with type 2 diabetes mellitus: a retrospective cohort study using a Japanese hospital database
    Yohei Morita
    Hiroki Murayama
    Masato Odawara
    Melissa Bauer
    Diabetology & Metabolic Syndrome, 11
  • [50] Dapagliflozin as Monotherapy in Drug-Naive Asian Patients With Type 2 Diabetes Mellitus: A Randomized, Blinded, Prospective Phase III Study
    Ji, Linong
    Ma, Jianhua
    Li, Hongmei
    Mansfield, Traci A.
    T'joen, Caroline L.
    Iqbal, Nayyar
    Ptaszynska, Agata
    List, James F.
    CLINICAL THERAPEUTICS, 2014, 36 (01) : 84 - 100
12345